September 20, 2021 -- Thermo Fisher Scientific announced that it has launched two new products. The first product is an adeno-associated virus (AAV) production system, while the second is a digital polymerase chain reaction (dPCR) system.
The Gibco AAV-MAX helper-free AAV production system aims to simplify the workflow involved in AAV vector production by delivering high viral titers using Viral Production Cells 2.0, a new, clonally documented, 293F-derived mammalian cell line.
Additionally, the company unveiled the Applied Biosystems QuantStudio Absolute Q digital PCR system, which is designed to provide highly accurate and consistent results within 90 minutes. The system uses microfluidic array technology and simpler workflows, and it was designed to improve the accuracy and consistency of data.
The dPCR technology powering the QuantStudio Absolute Q platform is used by biotech companies and academic institutions for longitudinal monitoring of cancer-driving mutations in liquid biopsy, precise quantification of gene inserts for cell therapy development, and copy-number variation studies for earlier identification of genetic conditions in newborns, the company said.